{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T08:59:23Z","timestamp":1781081963308,"version":"3.54.1"},"reference-count":14,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["transplantation-proceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.transproceed.2014.10.001","type":"journal-article","created":{"date-parts":[[2014,11,21]],"date-time":"2014-11-21T18:17:31Z","timestamp":1416593851000},"page":"3104-3107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Immunosuppression Based on Everolimus in Liver Transplant Recipients With Severe Early Post-transplantation Neurotoxicity"],"prefix":"10.1016","volume":"46","author":[{"given":"I.","family":"Bilbao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Dopazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Castells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Lazaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Caralt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Sapisochin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Charco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2014.10.001_bib1","first-page":"1042","article-title":"Neurological complications in liver transplantation","volume":"248","author":"Ghaus","year":"2001","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.transproceed.2014.10.001_bib2","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1432-2277.2008.00780.x","article-title":"Neurologic complications after solid organ transplantation","volume":"22","author":"Senzolo","year":"2009","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2014.10.001_bib3","first-page":"812","article-title":"Hepatic encephalopathy and post-transplant hyponatremia predict early calcineurin inhibitor\u2013induced neurotoxicity after liver transplantation","volume":"24","author":"Balderramo","year":"2011","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2014.10.001_bib4","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/lt.21427","article-title":"Age, Model for End-Stage Liver Disease score, and organ functioning predict posttransplant tacrolimus neurotoxicity","volume":"14","author":"DiMartini","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2014.10.001_bib5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s11011-012-9352-4","article-title":"Neurological complications post\u2013liver transplantation: impact of nutritional status","volume":"28","author":"Bermeur","year":"2013","journal-title":"Metab Brain Dis"},{"key":"10.1016\/j.transproceed.2014.10.001_bib6","first-page":"180","article-title":"Late fulminant posterior reversible encephalopathy syndrome after liver transplant","volume":"7","author":"Heidenhain","year":"2009","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.transproceed.2014.10.001_bib7","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1002\/lt.22383","article-title":"Changing pictures of central nervous system complications in liver transplant recipients","volume":"17","author":"Vizzini","year":"2011","journal-title":"Liver Transplantation"},{"key":"10.1016\/j.transproceed.2014.10.001_bib8","doi-asserted-by":"crossref","first-page":"924","DOI":"10.3174\/ajnr.A0960","article-title":"Posterior reversible encephalopathy after solid organ transplantation","volume":"29","author":"Bartynski","year":"2008","journal-title":"Am J Neuroradiol"},{"key":"10.1016\/j.transproceed.2014.10.001_bib9","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.clineuro.2010.07.023","article-title":"Presentation of reversible posterior leukoencephalopathy syndrome in patients on calcineurin inhibitors","volume":"112","author":"Burnett","year":"2010","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.transproceed.2014.10.001_bib10","doi-asserted-by":"crossref","first-page":"139","DOI":"10.12659\/AOT.882008","article-title":"Central pontine myelinolysis (CPM) associated with tacrolimus (FK506) after liver transplantation","volume":"16","author":"Fukazawa","year":"2011","journal-title":"Ann Transplant"},{"key":"10.1016\/j.transproceed.2014.10.001_bib11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00007890-199405820-00006","article-title":"Neurotoxicity after orthotopic liver transplantation. A comparison between cyclosporine and FK506","volume":"58","author":"Mueller","year":"1994","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2014.10.001_bib12","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1432-2277.2000.tb01004.x","article-title":"Neurotoxicity of calcineurin inhibitors: impact and clinical management","volume":"13","author":"Bechstein","year":"2000","journal-title":"Transpl Int"},{"key":"10.1016\/j.transproceed.2014.10.001_bib13","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1053\/jlts.2001.24645","article-title":"mTOR inhibitors: an overview","volume":"7","author":"Neuhaus","year":"2001","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2014.10.001_bib14","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2165\/00003495-200464080-00005","article-title":"Everolimus","volume":"64","author":"Chapman","year":"2004","journal-title":"Drugs"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134514010288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134514010288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T14:56:06Z","timestamp":1538060166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134514010288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":14,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0041134514010288"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2014.10.001","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunosuppression Based on Everolimus in Liver Transplant Recipients With Severe Early Post-transplantation Neurotoxicity","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2014.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}